Advertisement

Picture Berlin Partner Bionnale the Annual Life Sciences Event 650x80px

News > All

Total search results: 9445 | Ordered by Date (descending)
1 2 3 ... 93 94 95  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Coulter Partners. (5/13/22). "Press Release: Coulter Partners Expands Its Global Team with Key Appointments and a New Office in Italy". London. 2022-05-13
SciRhom GmbH. (5/12/22). "Press Release: SciRhom Announces Addition to the Management Team". Munich. 2022-05-12
Domain Therapeutics S.A.. (5/12/22). "Press Release: Domain Therapeutics Raises $42m Series A Financing to Accelerate Clinical Development of Its Best-in-Class and First-in-Class Immuno-oncology Programs". Strasbourg & Montréal, ON. 2022-05-12
Sofinnova Partners. (5/12/22). "Press Release: Sofinnova Partners Announces New Investment In Nanophoria, Developer Of An Innovative Non-viral Drug Delivery Platform". Milan. 2022-05-12
Sequentify Ltd.. (5/10/22). "Press Release: Democratizing Genomics, Sequentify Raises $7M to Enable DNA Sequencing at Scale". Rehovot. 2022-05-10
Hovione. (5/9/22). "Press Release: Hovione and Jixing Announce an Exclusive Global License Agreement for Ophthalmology Program". Lisbon & Shanghai. 2022-05-09
Consilium Strategic Communications Ltd.. (5/6/22). "Press Release: Consilium Strategic Communications Appoints Tracy Cheung as Partner". London. 2022-05-06
Bico Group AB. (5/6/22). "Press Release: Bico Acquires Allegro 3D, Adding New Light-based 3D Bioprinting Technology – Complementing the Existing Offering of Application Tailored products". 2022-05-06
Sidekick Health. (5/5/22). "Press Release: Sidekick Raises $55M Series B to Drive Further Growth". Berlin, Boston & Reykjavik. 2022-05-05
Byondis B.V.. (5/3/22). "Press Release: Byondis and Medac Enter into License and Collaboration and Supply Agreements for Anti-HER2 ADC Trastuzumab Duocarmazine (SYD985)". Nijmegen & Wedel. 2022-05-03
Tubulis GmbH. (5/3/22). "Press Release: Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies". Munich. 2022-05-03
Engimmune Therapeutics AG. (5/3/22). "Press Release: Engimmune Therapeutics Raises CHF 15.5 Million in Seed Financing to Develop Novel T-cell Receptor Therapeutics". Basel. 2022-05-03
AdBio Partners S.A.S.. (5/3/22). "Press Release: AdBio Partners Welcomes Inserm Transfert as Investor in Second Fund – AFB Fund II". Paris. 2022-05-03
Hemispherian AS. (5/3/22). "Press Release: Hemispherian Raises Seed Funding for Novel Cancer Therapeutics". Oslo. 2022-05-03
Selexis S.A.. (5/2/22). "Press Release: JSR Appoints Veteran Biotech and CDMO Leader Mark W. Womack to Lead KBI Biopharma and Selexis SA". Sunnyvale, CA. 2022-05-02
Corden Pharma International GmbH. (5/2/22). "Press Release: Astorg to Acquire Leading Pharmaceutical Contract Development & Manufacturing Organization CordenPharma from ICIG". Basel. 2022-05-02
Merck KGaA. (4/29/22). "Press Release: Merck Invests Approximately € 100 Million to Accelerate Single-Use Manufacturing in China". Darmstadt. 2022-04-29
OMass Therapeutics Ltd.. (4/28/22). "Press Release: OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases". Oxford. 2022-04-28
Quell Therapeutics Ltd.. (4/27/22). "Press Release: Quell Therapeutics and Cellistic Enter a Strategic Collaboration to Develop an iPSC-derived Allogeneic T-regulatory (Treg) Cell Therapy Platform". London & Gosselies. 2022-04-27
Bionter AG. (4/27/22). "Press Release: Bionter AG Secures $3 Million in Series Seed Financing Led by Dynamk Capital". Riehen. 2022-04-27
Toulouse White Biotech (TWB). (4/27/22). "Press Release: TWB Expands Its Industrial Biotechnology Solutions by Partnering with Processium and Syngulon". London & Gosselies. 2022-04-27
Moderna, Inc.. (4/27/22). "Press Release: Arpa Garay Joins Moderna as Chief Commercial Officer". Cambridge, MA. 2022-04-27
Berlin, State of. (4/26/22). "Press Release: Memorandum Signed on Establishing a Center of Gene and Cell Therapy – The State of Berlin, Bayer, and Charité Are Planning a Health Care Lighthouse Project in the Mitte Borough". Berlin. 2022-04-26
Mainz Biomed N.V.. (4/26/22). "Press Release: Mainz Biomed Appoints Darin Leigh as Chief Commercial Officer". Berkeley, CA & Mainz. 2022-04-26
Bico Group AB. (4/26/22). "Press Release: BICO’s CFO Gusten Danielsson Leaves His Assignment". 2022-04-26
Sygnature Discovery Ltd.. (4/26/22). "Press Release: Sygnature Discovery Acquires Peak Proteins, to Strengthen Its Drug Discovery Capabilities". Nottingham. 2022-04-26
Symeres. (4/26/22). "Press Release: Symeres Acquires Organix Inc., Adding Lipids Expertise and a Strategic Foothold in the US". Nijmegen. 2022-04-26
Apeiron Biologics AG. (4/26/22). "Press Release: Apeiron Shareholders Approve New Group Structure Geared towards Enabling Innovation and Growth". Vienna. 2022-04-26
ProteoNic. (4/26/22). "Press Release: ProteoNic and NecstGen Establish Partnership to Improve Viral Vector Manufacturing Efficiency for Gene Therapies". Leiden. 2022-04-26
Valneva S.E.. (4/25/22). "Press Release: Valneva Provides Regulatory Update on its inactivated COVID-19 Vaccine Candidate". Saint-Herblain. 2022-04-25
Stentit B.V.. (4/25/22). "Press Release: MedTech Company Stentit Raises €1.8 Million in Seed Round". Eindhoven. 2022-04-25
MitoRx Therapeutics Ltd.. (4/25/22). "Press Release: MitoRx Therapeutics Announces Seed Financing to Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases". Harwell. 2022-04-25
Biotest AG. (4/25/22). "Press Release: Grifols Acquires Majority of Voting Rights in Biotest". Dreieich. 2022-04-25
BenevolentAI. (4/25/22). "Press Release: BenevolentAI Begins Trading On Euronext Amsterdam". London. 2022-04-25
Euronext N.V.. (4/25/22). "Press Release: BenevolentAI Lists on Euronext Amsterdam. Listed Following Business Combination with Odyssey Acquisition S.A.". Amsterdam. 2022-04-25
SHS Gesellschaft für Beteiligungsmanagement mbH. (4/22/22). "Press Release: SHS and Yabeo Invest in the Leading Scandinavian Digital Health Platform Dr.Dropin". Tübingen & Oslo. 2022-04-22
Eppendorf SE. (4/22/22). "Press Release: Eppendorf Builds New Site in Wismar for High-tech Polymers Used in Laboratories". Wismar & Hamburg. 2022-04-22
CureVac N.V.. (4/21/22). "Press Release: CureVac and GSK’s Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study". Tübingen & Boston, MA. 2022-04-21
SHS Gesellschaft für Beteiligungsmanagement mbH. (4/21/22). "Press Release: SHS Sells Shares in Bochum-based Phenox GmbH, a Leading Manufacturer of Instruments and Implants for the Treatment of Stroke". Tübingen. 2022-04-21
VIB, Flanders Interuniversity Institute of Biotechnology. (4/20/22). "Press Release: Christine Durinx Joins VIB as Co-Managing Director". 2022-04-20
NLC Ventures Netherlands B.V.. (4/20/22). "Press Release: Charles River Laboratories and NLC Collaborate". 2022-04-20
Ramarketing. (4/20/22). "Press Release: NorthEdge Invests in Leading Life Sciences Marketing Specialist Ramarketing". 2022-04-20
Carl Zeiss Meditec AG. (4/19/22). "Press Release: Carl Zeiss Meditec Acquires Two Manufacturers of Surgical Instruments". Jena. 2022-04-19
Symrise AG. (4/14/22). "Press Release: Symrise Successfully Places €750 million ESG-linked Promissory Loan Notes". Holzminden. 2022-04-14
TreeFrog Therapeutics S.A.S.. (4/14/22). "Press Release: TreeFrog Therapeutics Expands Board with New Independent Members from the Cell Therapy Industry". Bordeaux. 2022-04-14
Hemerion Therapeutics S.A.S.. (4/14/22). "Press Release: Hemerion Therapeutics successfully raises over €3.5 million: a new hope for the treatment of brain cancer". Villeneuve d’Ascq. 2022-04-14
Affimed N.V.. (4/13/22). "Press Release: Affimed Announces Pricing of Upsized $90 Million Public Offering of Common Shares". Heidelberg. 2022-04-13
GlaxoSmithKline plc. (4/13/22). "Press Release: GSK Reaches Agreement to Acquire Late-stage Biopharmaceutical Company Sierra Oncology for $1.9bn". London. 2022-04-13
Terumo Blood and Cell Technologies. (4/13/22). "Press Release: CEO Antoinette Gawin Will Serve as Group Managing Executive Officer in Terumo Corporation’s New Executive Officers’ Management System". Lakewood, CO. 2022-04-13
BioCaptiva Ltd.. (4/13/22). "Press Release: BioCaptiva Appoints Alison Williamson as Chief Financial Officer and Board Director". Edinburgh. 2022-04-13
Monkeys not Donkeys. (4/13/22). "Press Release: Quality by Design (QbD) Acquires Marketing & Communication Agency ‘Monkeys not Donkeys’ to Strengthen Its Services within the Life Science Industry". Wilrijk & Ghent. 2022-04-13
Oxford BioTherapeutics Ltd.. (4/13/22). "Press Release: Oxford BioTherapeutics Grants Third Exclusive License to Boehringer Ingelheim for Development and Commercialization of Antibody Products to a Novel Oncology Target". Oxford & San Jose, CA. 2022-04-13
Cimeio Therapeutics AG. (4/13/22). "Press Release: Versant Ventures Launches Cimeio Therapeutics with $50 Million Series A". Basel & Boston, MA. 2022-04-13
CDR-Life AG. (4/13/22). "Press Release: CDR-Life Announces $76 Million Raised in Series A Funding". Zürich. 2022-04-13
Ribonexus. (4/12/22). "Press Release: Ribonexus Receives €2M in Deep Tech Financing from Bpifrance". Villejuif. 2022-04-12
Carmat S.A.. (4/12/22). "Press Release: Carmat Successfully Raises a Global Total of €40.5 Million via the Issuance of 4,054,282 Shares [NOT FOR RELEASE, EITHER DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN]". Paris. 2022-04-12
Affimed N.V.. (4/12/22). "Press Release: Affimed Announces Proposed Public Offering of Common Shares". Heidelberg. 2022-04-12
CureVac N.V.. (4/11/22). "Press Release: CureVac and GSK Enter into Pandemic Preparedness Contract with German Government". Tübingen & Boston, MA. 2022-04-11
BioNTech SE. (4/11/22). "Press Release: BioNTech and Matinas BioPharma Announce Exclusive Research Collaboration to Evaluate Novel Delivery Technology for mRNA-based Vaccines". Mainz & Beminster, NJ. 2022-04-11
Carlyle Group, The. (4/11/22). "Press Release: Carlyle Expands Leading Healthcare Franchise with Agreement to Acquire Life Sciences Investment Firm Abingworth". New York, NY. 2022-04-11
Carmat S.A.. (4/11/22). "Press Release: Carmat Launches a Capital Increase for an Amount of 30 Million Euros that Has Received Subscription Commitments Totaling 22 Million Euros [NOT FOR RELEASE, EITHER DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANAD 2022-04-11
Affimed N.V.. (4/10/22). "Press Release: Affimed Presents Updated Clinical Data from Phase 1/2 Study of AFM13 Precomplexed with Cord Blood-Derived NK Cells at AACR Annual Meeting". Heidelberg. 2022-04-10
TreeFrog Therapeutics S.A.S.. (4/8/22). "Press Release: TreeFrog Therapeutics Opens Technological Hub in Kobe, Japan, to Drive Partnerships Opportunities in the Field of iPSC-derived Cell Therapies". Kobe. 2022-04-08
Mireca Medicines GmbH. (4/8/22). "Press Release: Mireca Signs Transformative Deal with Nasdaq-listed Graybug Vision". Tübingen. 2022-04-08
H. Lundbeck A/S. (4/8/22). "Press Release: Joerg Hornstein to Join Lundbeck as Chief Financial Officer and Head of Corporate Functions". Valby. 2022-04-08
Affimed N.V.. (4/8/22). "Press Release: Affimed Presents Findings from the Dose-escalation Phase of the First-in-human Study of AFM24 in Patients with EGFR-positive Solid Tumors". Heidelberg. 2022-04-08
IonSense, Inc.. (4/7/22). "Press Release: IonSense, a Leader In DART Mass Spectroscopy, Announces Acquisition by Bruker to Accelerate DART-MS Methods and Applications Development". New York, NY, London & Research Triangle Park, NC. 2022-04-07
ReViral Ltd.. (4/7/22). "Press Release: Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates". New York, NY, London & Research Triangle Park, NC. 2022-04-07
Kynos Therapeutics Ltd.. (4/7/22). "Press Release: Kynos Therapeutics Emerges from Stealth with £9 Million Financing and Phase 1-ready KMO Inhibitor". Edinburgh. 2022-04-07
Catalent, Inc.. (4/6/22). "Press Release: Catalent Acquires Facility in Oxfordshire to Expand Biologics Capabilities in the UK and Across Europe". Somers, NJ. 2022-04-06
ViGeneron GmbH. (4/6/22). "Press Release: ViGeneron Signs Gene Therapy Strategic Collaboration and Option Agreement with Regeneron for One Inherited Retinal Disease Target". Munich. 2022-04-06
Balderton Capital. (4/6/22). "Press Release: Avi Medical Raises €50M to Put Preventative Healthcare and Digital Integration at Heart of Its Service". 2022-04-06
LimFlow S.A.. (4/6/22). "Press Release: LimFlow Raises $40 Million (€36 Million) in Series D Financing". Paris. 2022-04-06
Bruker Corporation. (4/5/22). "Press Release: Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies". Billerica, MA. 2022-04-05
DNA Script. (4/5/22). "Press Release: DNA Script Partners with Asia-Pacific Distributors as Part of Global Expansion to Meet Demand for Same-day Enzymatic DNA Synthesis". South San Francisco, CA & Paris. 2022-04-05
Merck KGaA. (4/5/22). "Press Release: Merck Advances BioProcessing Capabilities with Acquisition of MAST Platform from Lonza, a Leading Automated Bioreactor Sampling System". Darmstadt. 2022-04-05
AXA Investment Managers. (4/4/22). "Press Release: AXA IM Alts Launches $500 Million Private Equity Healthcare Strategy alongside Two Senior Appointments". 2022-04-04
Oxford Gene Technology Ltd.. (4/4/22). "Press Release: OGT Welcomes Adrian Smith as CEO". Oxford. 2022-04-04
CardioRenal S.A.S.. (4/4/22). "Press Release: CardioRenal Raises €3.3 Million". Grenoble. 2022-04-04
Labster ApS. (4/4/22). "Press Release: Labster Secures $47M in New Funding Tranche to Expand Global Opportunities for Virtual Science Laboratory Simulations". Copenhagen & Boston, MA. 2022-04-04
Novartis AG. (4/4/22). "Press Release (Ad hoc): Novartis Announces New Organizational Structure to Accelerate Growth, Strengthen Pipeline and Increase Productivity". Basel. 2022-04-04
Lundbeckfonden. (4/4/22). "Press Release: Lundbeck Foundation Shifts into New Biotech Gear. New unit Raises Ambitions in Denmark – Lundbeckfonden BioCapital". 2022-04-04
Bayer AG. (4/1/22). "Press Release: Breakthrough Innovation Forum. Bayer Set to Drive Breakthrough Innovations in the Life Sciences". Leverkusen. 2022-04-01
LGC Ltd.. (4/1/22). "Press Release: LGC Acquires Rapid Genomics, Bolstering Its Position in the Application of NGS for High-throughput Genotyping Market in AgBio". 2022-04-01
Biovox GmbH. (4/22). "Press Release: Successful Pre-Seed-Round for BIOVOX". 2022-04-01
Forbion Capital Partners. (3/31/22). "Press Release: Forbion Appoints Both Dr Ton Logtenberg and Dr Michael Hayden as Venture Partners". Naarden. 2022-03-31
Oxford Science Enterprises. (3/31/22). "Press Release: Oxford Science Enterprises Strengthens Investment Teams with Two New Appointments". 2022-03-31
Avantium N.V.. (3/31/22). "Press Release: Avantium Reaches Financial Close for its FDCA Flagship Plant". Amsterdam. 2022-03-31
Bayer AG. (3/31/22). "Press Release: Bayer to Strengthen Global Pharmaceuticals Production Network. Planned Investments of around €2bn over Next Three Years [Not intended for U.S. and UK Media]". Berlin. 2022-03-31
Abzena Ltd.. (3/31/22). "Press Release: Abzena Secures $65 Million in Additional Funding to Accelerate Growth and Expand Capacity". San Diego, CA. 2022-03-31
V-Bio Ventures. (3/31/22). "Press Release: V-Bio Ventures Raises EUR 110 Million for its Second Fund and Expands Team". Ghent. 2022-03-31
Affimed N.V.. (3/31/22). "Press Release: Affimed Reports 2021 Financial Results and Highlights Recent Operational Progress". Heidelberg. 2022-03-31
High-Tech Gründerfonds Management GmbH. (3/31/22). "Press Release: Improving ARDS Treatment with Digital Twins. Ebenbuild Secures Seed Financing Round Led by Bayern Kapital and High-Tech Gründerfonds". Munich, Bonn & Landshut. 2022-03-31
VectivBio Holding AG. (3/30/22). "Press Release: VectivBio Announces Japan License Deal and Loan Facility Agreement, Providing up to $117 Million to Fuel the Company Through Key Catalysts". Basel. 2022-03-30
Cytosurge AG. (3/30/22). "Press Release: Cytosurge Launches Cell Line Engineering Services Based on Proprietary FluidFM Technology". Zurich. 2022-03-30
Kadans Science Partner. (3/30/22). "Press Release: Europe’s Largest Commercial Lab Building to Be Built at Canary Wharf, London". 2022-03-30
CureVac N.V.. (3/30/22). "Press Release: CureVac and GSK Start Clinical Development of Second-generation COVID-19 Vaccine Candidate, CV2CoV". Tübingen & Boston, MA. 2022-03-30
Zealand Pharma A/S. (3/30/22). "Press Release: Zealand Pharma Appoints New Chief Executive Officer, Refocuses Strategy to Prioritize Research & Development and Streamlines Operations". Copenhagen & Boston, MA. 2022-03-30
Argenx SE. (3/29/22). "Press Release: Argenx Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs". Breda. 2022-03-29
XAnge (Alexis du Peloux). (3/29/22). "Press Release (Blog Post): Core Biogenesis – When a Deeptech Goes Faster than Eexpected, Let’s Speed Up!". 2022-03-29
1 2 3 ... 93 94 95  next pagenext page



Advertisement

Picture [iito] Fighting Customers 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture Berlin Partner Bionnale the Annual Life Sciences Event 650x80px

» top